First exit in ENEXIS portfolio, with Curaleaf acquiring Emmac Life Sciences for USD 286 million, to be paid 15% in cash and 85% in Curaleaf stock
2021-03-09 08:00:00
For more information please visit this link: https://ir.curaleaf.com/2021-03-09-Curaleaf-to-Enter-European-Cannabis-Market-with-Acquisition-of-EMMAC-Life-Sciences-Limited-Europes-Leading-Independent-Cannabis-Company